Search
for
Sort by
Research 481–510 of 1000+
- Alopecia
- General Dermatology
- News in brief
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- A practical guide for the study of human and murine sebaceous glands <i>in situ</i>
- Alopecia Areata
- Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata
- Skin manifestations of chronic kidney disease
- Cutaneous changes in patients with chronic renal failure on hemodialysis
- Therapeutic Androgen Receptor Ligands
- Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
- Novel iron oxide nanocarriers loading finasteride or dutasteride: Enhanced skin penetration for topical treatment of alopecia
- ACUTE ZINC DEPLETION SYNDROME DURING PARENTERAL HYPERALIMENTATION
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Effect of ethanol extract of plant mixture on hair regeneration in human dermal papilla cells and C57BL/6J mice
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- Hair Transplantation in the Cicatricial Alopecias
- Cardiac biopsy in myocarditis
- Mechanism of PPARα agonist in alopecia areata
- Real-World Treatment Patterns among Patients with Alopecia Areata in the USA: A Retrospective Claims Analysis
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question
- Alternative Medicine for Hair Loss
- Sentinel lymph node status is the strongest independent predictor for disease free and overall survival in patients with thick melanoma